Better Health, Brighter Future
Pricing Philosophy
Patients are at the heart of everything we do
Pricing Philosophy
Every day, we focus on developing therapies that improve patient outcomes, reduce disease burden and offer healthcare providers important new options that enable them to treat patients based on their individual needs. Once on the market, we continue to invest in our treatments to demonstrate value and improve patient outcomes. Our approach to pricing medicines in the U.S. reflects our strong commitment to bringing the right treatment options to patients who may benefit from them.
When we price a new medicine, we carefully consider our vision of continuing to discover, develop, research and market new medicines to address patients’ unmet needs. We thoughtfully work to ensure that the list price of the medicine reflects the value and innovation a treatment brings to patients, caregivers, the health care system and society.
The complexity of the U.S. health care system can significantly affect the affordability and accessibility of medications for patients. To promote broader access to our medications, Takeda may contract for discounts and rebates with various supply chain entities, including pharmacy benefit managers (PBMs) and payers. However, these entities may not use the discounts and rebates to reduce what patients pay for their medications. Therefore, we offer support programs to help eligible patients facing access and affordability challenges during their treatment journey.
Our annual gross and net increases for our U.S. portfolio have been in the single digits. We intend to continue to limit future price increases in the U.S. to single digits and will continue to offer support programs to help patients when accessing our medicines.